Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-3,300
Closed -$17K 2238
2023
Q4
$17K Sell
3,300
-11,258
-77% -$53.2K ﹤0.01% 2051
2023
Q3
$60K Buy
14,558
+11,258
+341% +$68.9K 0.01% 1392
2023
Q2
$24K Buy
3,300
+120
+4% +$456 ﹤0.01% 1732
2023
Q1
$7K Buy
3,180
+734
+30% +$2.73K ﹤0.01% 2514
2022
Q4
$9K Sell
2,446
-2,294
-48% -$13K ﹤0.01% 2747
2022
Q3
$29K Buy
4,740
+3,599
+315% +$27.4K ﹤0.01% 2317
2022
Q2
$5K Sell
1,141
-5,453
-83% -$47.7K ﹤0.01% 3663
2022
Q1
$83K Buy
6,594
+5,097
+340% +$56.2K ﹤0.01% 1832
2021
Q4
$18K Sell
1,497
-3,043
-67% -$53.7K ﹤0.01% 3200
2021
Q3
$82K Sell
4,540
-3,093
-41% -$34.2K ﹤0.01% 2086
2021
Q2
$85K Buy
+7,633
New +$120K ﹤0.01% 2015

Other funds holding AMTX

Cutler Group's AMTX Position: Q1 2024 in Review

Cutler Group sold out of Aemetis (AMTX) in Q1 2024, closing a stake of 3,300 shares — an estimated $17K sold.

Cutler Group first reported a position in AMTX in Q2 2021 and held it in 11 quarters. The position peaked at $85K in Q2 2021. 71 funds tracked by Wall St. Rank hold AMTX as of Q1 2024.

  • Cutler Group reported no remaining Aemetis position as of Q1 2024 after selling out during the quarter.
  • Cutler Group sold 3,300 Aemetis shares in Q1 2024, an estimated $17K.
  • Cutler Group first reported a position in Aemetis in Q2 2021 and held it in 11 quarters.
  • Cutler Group's Aemetis position peaked at $85K in Q2 2021.
  • 71 funds tracked by Wall St. Rank held Aemetis as of Q1 2024.

Based on Cutler Group's 13F filing for Q1 2024, filed 19 Apr 2024.